Nuevolution - six months ahead - six triggers
Exciting months ahead for Nuevolution - it is possible all six triggers are in place, and hopefully rock solid, already at year end. It will likely trigger a drastic revaluation of the stock.
Exciting months ahead for Nuevolution - it is possible all six triggers are in place, and hopefully rock solid, already at year end. It will likely trigger a drastic revaluation of the stock.
En av Nuevolutions konkurrenter Vitae Pharma förvärvas av Allergan för 639 musd, 250% av börskursen.
I kväll har Nuevolution presemterat sig för amerikanska marknaden på Rodman&Renshaw Global Investment Conference.
Se nypublicerad communityanalys. http://www.redeye.se/community/analyser
ROR gamma antagonist(inverse agonist)global pipeline There is a significant unmet medical need for oral (small molecule) drugs that are safe and effective in the treatment autoimmune diseases such as...